NCT07619768

Brief Summary

The goal of this study is to compare a Self-Regulation Hypnotic Intervention (SRHI) to the standard procedure (Treatment As Usual with analgesic and sedative agents) for pain and anxiety management during rectal cancer brachytherapy. Hypnotizability of patients undergoing this procedure will be assessed and those who are thought to need analgesic and sedative agents during the procedure will be distributed (sequentially adjusted randomization) in two groups, one that will be trained and assisted using hypnosis and one that will not. Procedural pain, anxiety, difficulty and patients' vital sign will be assessed. Our hypothesis is that patients in the hypnosis group will experience less pain and anxiety and will need less medication than those in the control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2013

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
9.5 years until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

April 1, 2016

Enrollment Period

2.2 years

First QC Date

November 16, 2015

Last Update Submit

May 27, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain and Anxiety Self Report

    Participant's self-reports of pain and anxiety will be obtained through the use of verbal Numeric Rating Scales (NRS) from 0 (no pain, no anxiety) to 10 (worst possible pain, worst possible anxiety). These scales are currently implemented at the Jewish General Hospital (JGH) , and the NRS for pain is recommended for use in clinical trials and in clinical guidelines for cancer-related pain .

    Perioperative/Periprocedural

  • Vital Signs

    Vital signs will be continuously recorded with a data collection computer (Moberg Research Inc., USA) connected to the patient's portable monitor (Philips Intellivue MP50) in the brachytherapy room using a serial-port cable, and specific events (i.e., before, during, and after brachytherapy) will be marked. Means of all vital signs will be calculated for one-minute duration at specific times as described in the procedure section.

    Perioperative/Periprocedural

  • Facial expressions of pain checklist

    Facial expressions of pain will be video recorded during brachytherapy using a behavioral checklist developed by one of the coinvestigator (Céline Gélinas). This checklist is a combination of two previously validated behavioral pain assessment tools i.e. the Pain Behavior Assessment Tool (PBAT;) and the Critical-Care Pain Observation Tool. The Facial Expression section includes 16 dichotomized items (yes/no).

    Perioperative/Periprocedural

Secondary Outcomes (9)

  • The Hypnotizability Induction Profile

    At recruitment

  • The Short Form 36 Health Survey Questionnaire (SF-36)

    Change from Before brachytherapy treatment to one month after surgery

  • European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30 and the supplemental for Colorectal 29 (EORTC-QLQ-C30 & EORTC-QLQ-CR29)

    Change from Before brachytherapy treatment to one month after surgery

  • The Patient Health Questionnaire 9 scale (PHQ-9)

    Change from Before brachytherapy treatment to one month after surgery

  • The Generalised Anxiety Disorder 7 scale (GAD-7)

    Change from Before brachytherapy treatment to one month after surgery

  • +4 more secondary outcomes

Study Arms (2)

Self-Regulation Hypnotic intervention

EXPERIMENTAL

The participants meet a psychologist and a research assistant for about 15 minutes to learn information about the study and hypnosis. Once the consent is signed, their hypnotizability level and general mental state is assessed. After that, the psychologist (experienced in clinical hypnosis) teaches patients how to use self-hypnosis during 40 minutes prior to treatment, and guides them throughout their treatment.

Behavioral: Self-Regulation hypnosis

Treatment As Usual

NO INTERVENTION

The participants meet a psychologist and a research assistant for about 15 minutes to learn information about the study and hypnosis. Once the consent is signed, their hypnotizability level and general mental state is assessed. After that, participants go on to their treatment with no additional intervention, but a research assistant collects data throughout their treatment.

Interventions

A psychologist specialised in clinical hypnosis teaches patients to use self-hypnosis and guides them through their treatment

Self-Regulation Hypnotic intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Score over 25 on the MMSE,
  • Fluent in english or french elected for brachytherapy treatment for rectal cancer

You may not qualify if:

  • Medication for pain, anxiety or depression on a non-regular basis.
  • Organic brain condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Radio-Oncology

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Te Vuong, MD

    Sir Mortimer B. Davis - Jewish General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Radio-Oncologist

Study Record Dates

First Submitted

November 16, 2015

First Posted

June 2, 2026

Study Start

July 1, 2013

Primary Completion

September 1, 2015

Study Completion

December 1, 2016

Last Updated

June 2, 2026

Record last verified: 2016-04

Locations